BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $77,862 | +55.5% | 1,232 | +10.7% | 0.01% | +57.1% |
| Q1 2023 | $50,074 | +2.7% | 1,113 | 0.0% | 0.01% | -12.5% |
| Q4 2022 | $48,761 | -78.8% | 1,113 | -68.1% | 0.01% | -78.9% |
| Q3 2022 | $230,000 | +30.7% | 3,486 | 0.0% | 0.04% | +35.7% |
| Q2 2022 | $176,000 | -21.1% | 3,486 | 0.0% | 0.03% | -6.7% |
| Q1 2022 | $223,000 | -40.2% | 3,486 | 0.0% | 0.03% | -36.2% |
| Q4 2021 | $373,000 | +4.2% | 3,486 | 0.0% | 0.05% | -4.1% |
| Q3 2021 | $358,000 | +16.6% | 3,486 | 0.0% | 0.05% | +16.7% |
| Q2 2021 | $307,000 | -4.4% | 3,486 | +5.6% | 0.04% | -12.5% |
| Q1 2021 | $321,000 | -10.3% | 3,300 | +3.3% | 0.05% | -15.8% |
| Q4 2020 | $358,000 | -24.2% | 3,196 | -37.3% | 0.06% | -36.7% |
| Q3 2020 | $472,000 | +50.8% | 5,095 | +26.9% | 0.09% | +36.4% |
| Q2 2020 | $313,000 | – | 4,015 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |